association

Full identifier: http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#association

Assigned to 1 class:

Minted in Nanopublication

 RA5oK7bpcr comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RA5oK7bpcr... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-08-23T18:41:12.827+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RA5oK7bpcr... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAhNHZw6Ur... RAhNHZw6Ur .
This is the identifier for this whole nanopublication. http://purl.org/np/RA5oK7bpcr... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RA5oK7bpcr... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T16:41:12.827Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
"Administration of Mifepristone tablets, 200mg and misoprostol for the termination of pregnancy (the ""treatment procedure"") is contraindicated in patients with any of the following conditions: - [ see Warnings and Precautions ( 5.4 - - - [ see Adverse Reactions ( 6.2 - - Use of Mifepristone tablets, 200mg and misoprostol for termination of intrauterine pregnancy is contraindicated in patients with an intrauterine device (""IUD"") in place (the IUD might interfere with pregnancy termination). If the IUD is removed, Mifepristone tablets, 200mg may be used. Confirmed/suspected ectopic pregnancy or undiagnosed adnexal mass ( 4 Chronic adrenal failure ( 4 Concurrent long-term corticosteroid therapy ( 4 History of allergy to mifepristone, misoprostol, or other prostaglandins ( 4 Hemorrhagic disorders or concurrent anticoagulant therapy ( 4 Inherited porphyria ( 4 Intrauterine device (IUD) in place ( 4"
Leoni Bücken
2021-08-23T16:41:12.827Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T16:41:12.827Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T16:41:12.827Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T16:41:12.827Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T16:41:12.827Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T16:41:12.827Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)